Aspirion, a leading healthcare revenue cycle management provider, has acquired Infinia ML, a top Artificial Intelligence (AI) and machine learning company. This strategic move is set to advance Aspirion's capabilities in intelligent automation, benefiting its healthcare clients with improved operational efficiency and revenue collection speed. Infinia ML will serve as Aspirion's research and development hub, focusing on AI technologies to enhance financial performance for healthcare providers nationwide. The acquisition underscores Aspirion's commitment to innovation and strengthening its position in the healthcare industry.

‍

Infinia ML's expertise in AI and data science, combined with Aspirion's deep experience in revenue cycle management, aims to deliver significant value to clients by addressing complex challenges. Spencer Allee, Chief AI Officer at Aspirion, highlighted the transformative potential of this partnership in utilizing AI to navigate intricate aspects of the healthcare revenue cycle.

‍